Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction
- 1 October 2016
- journal article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 220, 802-808
- https://doi.org/10.1016/j.ijcard.2016.06.077
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography dataEuroIntervention, 2015
- Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching ComparisonКАРДИОЛОГИЯ УЗБЕКИСТАНА, 2015
- A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialThe Lancet, 2014
- Percutaneous coronary interventions during ST-segment elevation myocardial infarction: current status and future perspectivesEuroIntervention, 2014
- Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'.European Heart Journal, 2014
- Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first studyEuropean Heart Journal, 2014
- Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque?Atherosclerosis, 2012
- 6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mmJournal of the American College of Cardiology, 2011
- Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisCirculation, 2010
- A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methodsThe Lancet, 2009